7401. A comparison of ultrasonography and magnetic resonance imaging in the evaluation of temporomandibular joint involvement in rheumatoid arthritis and psoriatic arthritis.
作者: D Melchiorre.;A Calderazzi.;S Maddali Bongi.;R Cristofani.;L Bazzichi.;C Eligi.;M Maresca.;M Ciompi.
来源: Rheumatology (Oxford). 2003年42卷5期673-6页
To define the diagnostic value of ultrasonographic (US) examination in comparison with magnetic resonance imaging (MRI) for the assessment of temporomandibular joint (TMJ) involvement in rheumatoid arthritis (RA) and psoriatic arthritis (PsA).
7402. Suppressive effects of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice.
作者: S S Shin.;M Jin.;H J Jung.;B Kim.;H Jeon.;J J Choi.;J M Kim.;B W Cho.;S H Chung.;Y W Lee.;Y W Song.;Sunyoung Kim.
来源: Rheumatology (Oxford). 2003年42卷5期665-72页
PG201 has been formulated using 12 herbs known to have anti-inflammatory and protective effects on damaged tissue and bone among other functions. The present study was done in order to assess the therapeutic effects of PG201 in collagen-induced arthritis (CIA) in mice.
7403. Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: a case-control study.
作者: A Eden.;A Mahr.;A Servant.;N Radjef.;S Amard.;L Mouthon.;A Garbarg-Chenon.;L Guillevin.
来源: Rheumatology (Oxford). 2003年42卷5期660-4页
To examine the potential association of human B19 or V9 erythrovirus infection and onset of ANCA-positive vasculitides.
7404. Herbal medicines for the treatment of rheumatoid arthritis: a systematic review.
With the growing interest in herbal therapies among persons with rheumatoid arthritis, there exists a need for investigation into their safety and efficacy. The purpose of this study was to conduct a systematic review to examine the evidence for the use of herbal medicines for RA based on randomized clinical trials (RCTs).
7405. Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study.
作者: P G Vlachoyiannopoulos.;P G Kanellopoulos.;J P A Ioannidis.;M G Tektonidou.;I Mastorakou.;H M Moutsopoulos.
来源: Rheumatology (Oxford). 2003年42卷5期645-51页
To evaluate whether premenopausal women with antiphospholipid syndrome (APS) or systemic lupus erythematosus (SLE) have increased prevalence of atherosclerosis after adjustment has been made for known cardiovascular risk factors.
7406. BiP, a putative autoantigen in rheumatoid arthritis, stimulates IL-10-producing CD8-positive T cells from normal individuals.
作者: M D Bodman-Smith.;V M Corrigall.;D M Kemeny.;G S Panayi.
来源: Rheumatology (Oxford). 2003年42卷5期637-44页
We have reported that synovial fluid T cells from patients with rheumatoid arthritis (RA) proliferate in response to the endoplasmic reticulum molecular chaperone immunoglobulin binding protein (BiP). The aim of the present work was to clone and define T cells responding to this protein.
7407. The prevalence of antibodies against Sindbis-related (Pogosta) virus in different parts of Finland.
作者: M Laine.;R Vainionpää.;J Oksi.;R Luukkainen.;A Toivanen.
来源: Rheumatology (Oxford). 2003年42卷5期632-6页
To study the occurrence of Sindbis-related (Pogosta) disease in Finland by serological means.
7408. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring data.
and objectives. Non-steroidal anti-inflammatory drugs (NSAIDs) are associated with gastrointestinal (GI) toxicity. Rofecoxib and meloxicam are classified as cyclooxygenase (COX)-2 selective inhibitors. The Drug Safety Research Unit monitored the safety of these drugs immediately after their launch in England using the non-interventional observational cohort technique of prescription-event monitoring (PEM). Our objective was to investigate whether there is a clinically relevant difference in the incidence of reported symptomatic (acid/peptic) and complicated upper GI conditions (perforations/bleeding) between rofecoxib and meloxicam during use in general practice.
7409. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy.
With rising numbers of anti-tumour necrosis factor alpha (TNF-alpha) treatments for rheumatoid arthritis (RA), Crohn's disease and other conditions, physicians unaware of potential pitfalls are increasingly likely to encounter associated severe infections. Our purpose was to assess the incidence and nature of severe infections in our RA patients under anti-TNF-alpha therapy.
7410. Biologic therapy in clinical practice: enthusiasm must be tempered by caution.7418. The physiological and physical determinants of functional ability measures in children with juvenile dermatomyositis.
作者: T Takken.;E Elst.;N Spermon.;P J M Helders.;A B J Prakken.;J van der Net.
来源: Rheumatology (Oxford). 2003年42卷4期591-5页
To study the relationships of muscle strength and maximal oxygen consumption (VO(2peak)) with Childhood Health Assessment Questionnaire (CHAQ) score, Childhood Myositis Assessment Score (CMAS) and Child Health Questionnaire [physical summary (CHQ-PhS) and psychosocial summary (CHQ-PsS)] scores in juvenile dermatomyositis.
7419. Synovial dendritic cells in juvenile idiopathic arthritis (JIA) express receptor activator of NF-kappaB (RANK).
作者: H Varsani.;A Patel.;Y van Kooyk.;P Woo.;L R Wedderburn.
来源: Rheumatology (Oxford). 2003年42卷4期583-90页
To analyse the expression of receptor activator of NF-kappaB (RANK) and RANK ligand (RANKL) in the joints of children with juvenile idiopathic arthritis (JIA), to characterize the phenotype of RANK(+) cells and to test the hypothesis that some RANK(+) cells are of the dendritic type.
|